TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32565468

Group type: EXPERIMENTAL
Intervention: RCTs assessed using the CONSORT 2010 Statement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Descriptive statistics and secondary analyses
Number of subjects: 0
Study: 36241511

Group type: EXPERIMENTAL
Intervention: Tranexamic acid administered before surgical incision (pre-induction groups)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Tranexamic acid administered just before tourniquet release (pre-release groups)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Single-dose groups (tranexamic acid administered once)
Number of subjects: 212

Group type: COMPARATOR
Intervention: Double-dose groups (tranexamic acid administered twice)
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Single-dose groups
Number of subjects: 212

Group type: COMPARATOR
Intervention: Double-dose groups
Number of subjects: 212
Study: 34878081

Group type: EXPERIMENTAL
Intervention: Antibiotic paste (CTZ)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Iodoform paste (GP)
Number of subjects: 52
Study: 33991032

Group type: EXPERIMENTAL
Intervention: Carboxytherapy (intradermal injection of 5 cc carbon-dioxide gas once weekly for 6 weeks)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) therapy (intradermal injection of PRP every 2 weeks for three times)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Comparison of carboxytherapy and PRP
Number of subjects: 21
Study: 35183487

Group type: EXPERIMENTAL
Intervention: Pain Indicator Behaviour Scale
Number of subjects: 80

Group type: COMPARATOR
Intervention: Verbal Numerical Scale or Visual Analogue Scale
Number of subjects: 80
Study: 33709907

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg daily
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 33061349

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 25 mcg BID
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycopyrrolate 50 mcg BID
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 616083574

Group type: COMPARATOR
Intervention: Paper based manual training
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: EyeSi simulator training
Number of subjects: 19
Study: 32584415

Group type: EXPERIMENTAL
Intervention: Certolizumab pegol (CZP) treatment
Number of subjects: 672
Study: 32466879

Group type: EXPERIMENTAL
Intervention: Mavacamten (200 ng/ml)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Mavacamten (500 ng/ml)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 35584934

Group type: EXPERIMENTAL
Intervention: Alumina-ceria polishing paste with different ratios of deionized water:alumina:ceria (AC0.5, AC1, AC1.5, AC2, AC2.5, AC3)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Diamond paste (Control group)
Number of subjects: 70
Study: 32920767

Group type: EXPERIMENTAL
Intervention: 40 Gy equivalent dose
Number of subjects: 200

Group type: COMPARATOR
Intervention: 50 Gy equivalent dose
Number of subjects: 200
Study: 32629757

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (6000 IU daily for eight weeks)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 28
Study: 35093047

Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based cognitive behavioral therapy (iCBT) youthCOACHCD (IG, n=15)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Waitlist control group (CG, n=15) receiving unguided version of iCBT six months post-randomization
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Guided internet- and mobile-based cognitive behavioral therapy (iCBT) youthCOACHCD (IG)
Number of subjects: 30
Study: 33063528

Group type: EXPERIMENTAL
Intervention: Moderate and vigorous physical activities (MVPA) among Met/Met carriers
Number of subjects: 3040

Group type: COMPARATOR
Intervention: Moderate and vigorous physical activities (MVPA) among Val/Val and Val/Met carriers
Number of subjects: 3040
Study: 35597965

Group type: EXPERIMENTAL
Intervention: Multidisciplinary rehabilitation program combining multimodal exercises with psychologist-led cognitive-behavioral therapy sessions
Number of subjects: 170

Group type: COMPARATOR
Intervention: General care physiotherapy
Number of subjects: 170
Study: 34812096

Group type: EXPERIMENTAL
Intervention: Microneedle fractional radiofrequency (MFR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Fractional erbium-doped glass 1,565-nm laser (NAFL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Both treatments (MFR and NAFL)
Number of subjects: 15
Study: 35488479

Group type: EXPERIMENTAL
Intervention: Flapless endoscope-assisted osteotome sinus floor elevation with platelet-rich fibrin (PRF)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Lateral sinus floor elevation (LSFE) using deproteinised bovine bone matrix
Number of subjects: 40
Study: 33607008

Group type: EXPERIMENTAL
Intervention: lumacaftor–ivacaftor therapy
Number of subjects: 0
Study: 32524940

Group type: EXPERIMENTAL
Intervention: Maternal depression (measured by Patient Health Questionnaire‐9)
Number of subjects: 3984

Group type: EXPERIMENTAL
Intervention: Maternal and paternal depression (measured by Patient Health Questionnaire‐9)
Number of subjects: 3984

Group type: EXPERIMENTAL
Intervention: Children's dietary diversity
Number of subjects: 3984

Group type: EXPERIMENTAL
Intervention: Children's anthropometric status
Number of subjects: 3984

Group type: EXPERIMENTAL
Intervention: Moderate or severe depression screening
Number of subjects: 3984
Study: 36448651

Group type: EXPERIMENTAL
Intervention: Decision Aid plus Victorian Assisted Reproductive Technology Authority website
Number of subjects: 0

Group type: COMPARATOR
Intervention: Victorian Assisted Reproductive Technology Authority website only
Number of subjects: 0
Study: 35802168

Group type: EXPERIMENTAL
Intervention: Canagliflozin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 5

Group type: COMPARATOR
Intervention: Glimepiride
Number of subjects: 5

Group type: COMPARATOR
Intervention: Canagliflozin vs Placebo
Number of subjects: 5
Study: 34878076

Group type: EXPERIMENTAL
Intervention: TiF4 (2.45% F‐)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: NaF (2.26% F‐)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 33705500

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO)
Number of subjects: 129883
Study: 32779195

Group type: EXPERIMENTAL
Intervention: Early antiretroviral therapy (ART)
Number of subjects: 133
Study: 35867285

Group type: EXPERIMENTAL
Intervention: 980-nm diode laser
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional flap surgery
Number of subjects: 15
Study: 33398520

Group type: EXPERIMENTAL
Intervention: Eculizumab
Number of subjects: 143

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study: 32796869

Group type: EXPERIMENTAL
Intervention: Adaptive Neuro-Fuzzy Inference System (ANFIS) method
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ANFIS method
Number of subjects: 0
Study: 36136236

Group type: EXPERIMENTAL
Intervention: RET
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: RET-FO
Number of subjects: 28

Group type: COMPARATOR
Intervention: CON
Number of subjects: 28
Study: 32772069

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 117
Study: 35230676

Group type: EXPERIMENTAL
Intervention: Active tDCS + PT
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham tDCS + PT
Number of subjects: 25
Study: 34761730

Group type: EXPERIMENTAL
Intervention: Muse (game-based meditation intervention)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 77
Study: 35436611

Group type: EXPERIMENTAL
Intervention: SpikoGen® vaccine (25 μg, two doses, 3 weeks apart)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study: 33990433

Group type: EXPERIMENTAL
Intervention: Structured intervention programme including a 1 day education session and an individual written exercise plan over 4 months.
Number of subjects: 163

Group type: COMPARATOR
Intervention: Control group continued with their usual level of care.
Number of subjects: 163
Study: 32978182

Group type: EXPERIMENTAL
Intervention: Mirror Therapy (MT) combined with task-oriented training
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Cognitive Therapeutic Exercise (CTE) combined with task-oriented training
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control group (no additional interventions)
Number of subjects: 154
Study: 35570288

Group type: EXPERIMENTAL
Intervention: Menstrual migraine patients
Number of subjects: 109

Group type: COMPARATOR
Intervention: Non-menstrual migraine patients
Number of subjects: 109
Study: 33794005

Group type: EXPERIMENTAL
Intervention: Football Fitness (FFG)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 68
Study: 36252934

Group type: EXPERIMENTAL
Intervention: 10 mg lutein + 2 mg zeaxanthin
Number of subjects: 288

Group type: COMPARATOR
Intervention: Waitlist placebo
Number of subjects: 288
Study: 32363968

Group type: EXPERIMENTAL
Intervention: Intrauterine infusion of 0.5 ml of platelet-rich plasma (PRP) 48 hours before embryo transfer
Number of subjects: 98

Group type: COMPARATOR
Intervention: Standard protocol (Control)
Number of subjects: 98
Study: 32938470

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) starting from 5 mg per week for the first 2 weeks, increasing to 10 mg per week for the second 2 weeks, and 15 mg per week for the remaining period if tolerated
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34614204

Group type: EXPERIMENTAL
Intervention: 0.6 mg ramosetron with IV-PCA
Number of subjects: 88

Group type: COMPARATOR
Intervention: 10 mg dexamethasone before induction of anesthesia with IV-PCA
Number of subjects: 88
Study: 34753844

Group type: EXPERIMENTAL
Intervention: Licorice mouthwash
Number of subjects: 52

Group type: COMPARATOR
Intervention: Chlorhexidine mouthwash
Number of subjects: 52
Study: 32925205

Group type: EXPERIMENTAL
Intervention: Fluorescent guided surgery with 5-aminolevulinic acid
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tumor-treating fields therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focused ultrasound combined with microbubbles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ultrasound devices to disrupt the blood-brain barrier
Number of subjects: 0
Study: 35417339

Group type: EXPERIMENTAL
Intervention: High-intensity (HI) variant of the programme
Number of subjects: 695

Group type: COMPARATOR
Intervention: Low-intensity (LI) variant of the programme
Number of subjects: 695
Study: 32112583

Group type: EXPERIMENTAL
Intervention: Operative group (13 participants)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Nonoperative group (28 participants)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (8 participants)
Number of subjects: 49
Study: 35047630

Group type: EXPERIMENTAL
Intervention: Ulinastatin combined with Xingnaojing injection
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ulinastatin only
Number of subjects: 100
Study: 33059762

Group type: EXPERIMENTAL
Intervention: EACH-B intervention
Number of subjects: 2300

Group type: COMPARATOR
Intervention: Control (normal schooling)
Number of subjects: 2300
Study: 36202884

Group type: EXPERIMENTAL
Intervention: Lactobacillus fermentum CECT5716 during needle aspiration
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (no probiotics)
Number of subjects: 101
Study: 33707597

Group type: EXPERIMENTAL
Intervention: Sanqi seedlings cultivated in plots with varying soil parameters
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Soil pH
Number of subjects: 7
Study: 32816561

Group type: EXPERIMENTAL
Intervention: Iopamidol I-370
Number of subjects: 65

Group type: COMPARATOR
Intervention: Ioversol I-320
Number of subjects: 65
Study: 35851370

Group type: EXPERIMENTAL
Intervention: Desarda repair
Number of subjects: 100

Group type: COMPARATOR
Intervention: Lichtenstein repair
Number of subjects: 100
Study: 33156402

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (IN-OT)
Number of subjects: 0
Study: 35107599

Group type: EXPERIMENTAL
Intervention: Tibetan yoga program (TYP)
Number of subjects: 227

Group type: EXPERIMENTAL
Intervention: Stretching program (STP)
Number of subjects: 227

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 227
Study: 34626958

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 11
Study: 34014451

Group type: EXPERIMENTAL
Intervention: Nurtured in Nature intervention (4-week intervention with Nature Coach, digital nudges, personalized goal feedback)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Nurtured in Nature intervention (among women who completed the intervention)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 36
Study: 34290069

Group type: EXPERIMENTAL
Intervention: Calcipex
Number of subjects: 60

Group type: COMPARATOR
Intervention: Metapex
Number of subjects: 60
Study: 32499263

Group type: EXPERIMENTAL
Intervention: Serial ultrasound examinations of the heart and lungs together with standard care
Number of subjects: 206

Group type: COMPARATOR
Intervention: Standard monitoring alone
Number of subjects: 206
Study: 36409064

Group type: EXPERIMENTAL
Intervention: CTN-1 V human rabies vaccine (Vero cells) administered via the Essen Regimen (single dose on days 0, 3, 7, 14, and 28)
Number of subjects: 594

Group type: EXPERIMENTAL
Intervention: CTN-1 V human rabies vaccine (Vero cells)
Number of subjects: 594
Study: 33586072

Group type: EXPERIMENTAL
Intervention: Conventional chemoradiation therapy after induction chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Irreversible electroporation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combinations of local ablation and immunotherapy
Number of subjects: 0
Study: 36105647

Group type: EXPERIMENTAL
Intervention: Bud planting method with potato buds of 7 cm length (T3)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Bud planting method with terminal buds (T4)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Bud planting method with different lengths (3 cm, 5 cm, 7 cm)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Natural control (CK) treatment
Number of subjects: 4
Study: 33926922

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham transplantation
Number of subjects: 31
Study: 35363600

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline FVC bronchodilator responsiveness
Number of subjects: 0

Group type: COMPARATOR
Intervention: Early lung function reduction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interactions between lung function reduction and treatment assignment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Baseline bronchodilator responsiveness measures
Number of subjects: 0
Study: 33529588

Group type: EXPERIMENTAL
Intervention: 0.25% topical ocular reproxalap
Number of subjects: 300

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 300
Study: 33382780

Group type: EXPERIMENTAL
Intervention: Probiotic (Hexbio®) containing Lactobacillus sp and Bifidobacterium sp at 30 X 10^9 CFU with fructo-oligosaccharide
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Probiotic (Hexbio®)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (fermented milk)
Number of subjects: 48
Study: 35400075

Group type: EXPERIMENTAL
Intervention: 15-min aerobic exercise
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 15-min sitting naps
Number of subjects: 74

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 74
Study: 33904659

Group type: EXPERIMENTAL
Intervention: Morning exercise (7:00)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Afternoon exercise (16:00)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 11
Study: 32326902

Group type: EXPERIMENTAL
Intervention: Nurse mentor supported facilities
Number of subjects: 5240

Group type: COMPARATOR
Intervention: Other facilities or home deliveries
Number of subjects: 5240
Study: 35882461

Group type: EXPERIMENTAL
Intervention: Implementation support package consisting of evidence-based strategies (remind clinicians; facilitation; conduct educational meetings; develop a formal implementation blueprint; purposely re-examine the implementation; conduct ongoing training)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Implementation support package
Number of subjects: 0
Study: 32333057

Group type: EXPERIMENTAL
Intervention: Attune TKA
Number of subjects: 200

Group type: COMPARATOR
Intervention: PFC Sigma
Number of subjects: 200
Study: 36288835

Group type: EXPERIMENTAL
Intervention: Selinexor, cyclophosphamide and prednisolone (SCP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cyclophosphamide and prednisolone (CP)
Number of subjects: 0
Study: 34784373

Group type: EXPERIMENTAL
Intervention: rTMS (15 Hz)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 62
Study: 34788741

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Exercise (HIIE) - walking/jogging at RPE 11-17 for 25 minutes
Number of subjects: 15

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE) - walking at RPE 11-13 for 30 minutes
Number of subjects: 15
Study: 33179456

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 1848

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1848
Study: 36184209

Group type: EXPERIMENTAL
Intervention: High-protein dairy drink
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Energy-enriched berry purées
Number of subjects: 25

Group type: COMPARATOR
Intervention: Protein-free reference
Number of subjects: 25

Group type: COMPARATOR
Intervention: Low-berry reference
Number of subjects: 25
Study: 32895334

Group type: EXPERIMENTAL
Intervention: Water-Assisted Sigmoidoscopy (WAS)
Number of subjects: 1123

Group type: COMPARATOR
Intervention: CO2 technique
Number of subjects: 1123
Study: 32408117

Group type: EXPERIMENTAL
Intervention: Saffron supplementation (100 mg/day)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Saffron supplementation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33737036

Group type: EXPERIMENTAL
Intervention: iStent inject®
Number of subjects: 505

Group type: COMPARATOR
Intervention: surgery alone
Number of subjects: 505
Study: 32649638

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP) therapy
Number of subjects: 241
Study: 34047206

Group type: EXPERIMENTAL
Intervention: Perceived importance of physical activity (PA) before/after school
Number of subjects: 1015
Study: 32876858

Group type: EXPERIMENTAL
Intervention: Qingfei Yihuo Capsules (QYCs)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 35230212

Group type: EXPERIMENTAL
Intervention: BetterBack model of care (MoC)
Number of subjects: 500

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 500
Study: 33563546

Group type: EXPERIMENTAL
Intervention: Axial slicing
Number of subjects: 128

Group type: COMPARATOR
Intervention: Bivalving
Number of subjects: 128
Study: 32162502

Group type: EXPERIMENTAL
Intervention: Core Strength Training (CST)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 20
Study: 36451559

Group type: EXPERIMENTAL
Intervention: Licorice gargle juice for 1 and 2 days
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 33100187

Group type: EXPERIMENTAL
Intervention: Group Cognitive Behavioral Therapy (CBT) for 12 weeks
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 62
Study: 32790451

Group type: EXPERIMENTAL
Intervention: MEMS (Mobile Enhancement of Motivation in Schizophrenia)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 56
Study: 35972345

Group type: EXPERIMENTAL
Intervention: CIRAS model (developed using variables: ascites discomfort score, plasma sodium levels, and a composite of ascites accumulation and diuretic treatment)
Number of subjects: 1162

Group type: EXPERIMENTAL
Intervention: CIRAS model
Number of subjects: 1162
Study: 34845062

Group type: COMPARATOR
Intervention: Weight Loss (WL)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Glycemic Excursion Minimization (GEM)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: GEM
Number of subjects: 172
Study: 35643868

Group type: EXPERIMENTAL
Intervention: Bosutinib 400 mg once daily
Number of subjects: 536

Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 536
Study: 34544463

Group type: EXPERIMENTAL
Intervention: Solnatide (AP301), administered twice daily for 7 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo, administered twice daily for 7 days
Number of subjects: 0
Study: 32998815

Group type: EXPERIMENTAL
Intervention: Immunosuppression
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intensive supportive care
Number of subjects: 0
Study: 35189571

Group type: EXPERIMENTAL
Intervention: Tongue isometric pressure exercises using the Iowa Oral Performance Instrument with an increasing scheme of 5% load weekly and traditional tongue therapy for 8 weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 60
Study: 32789772

Group type: EXPERIMENTAL
Intervention: Regular CAT sub-registry
Number of subjects: 1128

Group type: EXPERIMENTAL
Intervention: Special CAT sub-registry
Number of subjects: 1128
Study: 32677390

Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 101

Group type: COMPARATOR
Intervention: Simple ESTD (Control)
Number of subjects: 101
Study: 34255938

Group type: EXPERIMENTAL
Intervention: Acarbose/Metformin Fixed-Dose Combination (50 mg/500 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Loose combination of individual components (Acarbose and Metformin)
Number of subjects: 0
Study: 32516507

Group type: EXPERIMENTAL
Intervention: ProDesign Logic rotary files
Number of subjects: 88

Group type: COMPARATOR
Intervention: K-file hand files
Number of subjects: 88
Study: 33036918

Group type: EXPERIMENTAL
Intervention: Counting and goal setting intervention (n = 85)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group (n = 80)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Intervention group vs Control group
Number of subjects: 165
Study: 34644419

Group type: EXPERIMENTAL
Intervention: Lidocaine 10% spray (50 mg)
Number of subjects: 539

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 539